Zeynep Arslantas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zeynep Arslantas has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Anil Erturk
Department of Obstetrics and Gynecology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
1 shared publication - Elmas Korkmaz
Kartal Dr. Lutfi Kirdar Educational and Research Hospital, Turkey
1 shared publication - Nergis Kender Erturk
Department of Obstetrics and Gynecology, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
1 shared publication - Sena Bekdemir
University of Health Sciences, Turkey
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (5) , e20231115
Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer
Endometrial cancer is the most common gynecological cancer in developed countries, with a majority of cases being low-grade endometrioid endometrial cancer. Identifying risk factors for disease recurrence and poor prognosis is critical. This study aimed to assess the correlation between preoperative cancer antigen-125 levels and disease recurrence in early-stage endometrioid endometrial cancer patients.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (5) , e20231115
Open AccessPreoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer
Endometrial cancer is the most common gynecological cancer in developed countries, with a majority of cases being low-grade endometrioid endometrial cancer. Identifying risk factors for disease recurrence and poor prognosis is critical. This study aimed to assess the correlation between preoperative cancer antigen-125 levels and disease recurrence in early-stage endometrioid endometrial cancer patients.